Coeliac Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are currently eating a diet that contains gluten, have a blood test showing raised levels of a celiac disease antibody (called TGt-IgA) above the normal range, and have had an intestinal biopsy confirming celiac disease.
- People whose intestinal biopsy results show a specific pattern of immune cells — higher than normal levels of a type called TCRγδ+ cells (above 10%) along with lower than normal levels of another type called NK-like intraepithelial lymphocytes (confirm with trial site).
- Children who meet specific European guidelines for diagnosing celiac disease, meaning their TGt-IgA antibody levels are more than 10 times the upper limit of normal, even without having had an intestinal biopsy.
Who may not be able to join:
- People who have already been formally diagnosed with celiac disease before joining the study.
- People who have refused to have a biopsy of their small intestine (duodenal biopsy).
- People who have a condition that weakens their immune system, whether they were born with it or developed it later.
- People who have or have had cancer.
- People whose blood samples cannot be sent to the central reference laboratory, whose biopsy samples are too poor in quality to be analysed, or who have not signed the required consent form.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marta Molero-Luis, Dr, Hospital Universitario La Paz
Phone: 0034660065755
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Anti-transglutaminase-IgA titer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.